(Q38743116)

English

The effectiveness of pneumococcal polysaccharide vaccine 23 (PPV23) in the general population of 50 years of age and older: A systematic review and meta-analysis

scientific article published on 17 February 2016

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

0 references

The effectiveness of pneumococcal polysaccharide vaccine 23 (PPV23) in the general population of 50 years of age and older: A systematic review and meta-analysis (English)

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

1 reference

based on heuristic

inferred from title

systematic review

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Caroline Quach-Thanh

object named as

Caroline Quach

3

0 references

author name string

Hannah Kraicer-Melamed

1

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

Shauna O'Donnell

2

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

language of work or name

0 references

publication date

17 February 2016

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

number of pages

11

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

34

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

13

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

1540-1550

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990-2013: quantifying the epidemiological transition

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.02.024

7 January 2021

Polysaccharide conjugate vaccine against pneumococcal pneumonia in adults.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.02.024

7 January 2021

Current methods of the US Preventive Services Task Force: a review of the process

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.02.024

7 January 2021

Pneumococcal disease after pneumococcal vaccination: an alternative method to estimate the efficacy of pneumococcal vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.02.024

7 January 2021

Meta-analysis in clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.02.024

7 January 2021

Bias in meta-analysis detected by a simple, graphical test

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.02.024

7 January 2021

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.02.024

7 January 2021

Meta-analysis of Observational Studies in Epidemiology: A Proposal for Reporting

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.02.024

7 January 2021

The 23-valent pneumococcal polysaccharide vaccine is effective in elderly adults over 75 years old--Taiwan's PPV vaccination program.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.02.024

7 January 2021

Invasive pneumococcal disease epidemiology and effectiveness of 23-valent pneumococcal polysaccharide vaccine in Alaska Native adults

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.02.024

7 January 2021

Environmental risk factors for community-acquired pneumonia hospitalization in older adults.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.02.024

7 January 2021

Estimation of vaccine effectiveness using the screening method.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.02.024

7 January 2021

Effectiveness of a publicly funded pneumococcal vaccination program against invasive pneumococcal disease among the elderly in Victoria, Australia.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.02.024

7 January 2021

Effectiveness of 23-valent pneumococcal polysaccharide vaccine in adults aged 60 years and over in the Region of Madrid, Spain, 2008-2011.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.02.024

7 January 2021

The impact and effectiveness of pneumococcal vaccination in Scotland for those aged 65 and over during winter 2003/2004

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.02.024

7 January 2021

Pneumococcal vaccination programs and the burden of invasive pneumococcal disease in Ontario, Canada, 1995-2011.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.02.024

7 January 2021

Impact of pneumococcal polysaccharide vaccine in people aged 65 years or older

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.02.024

7 January 2021

Impact of a combined pediatric and adult pneumococcal immunization program on adult pneumonia incidence and mortality in Nicaragua

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.02.024

7 January 2021

Protective Effects of the 23‐Valent Pneumococcal Polysaccharide Vaccine in the Elderly Population: The EVAN‐65 Study

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.02.024

7 January 2021

Impact and effectiveness of 23-valent pneumococcal polysaccharide vaccine against invasive pneumococcal disease in the elderly in England and Wales.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.02.024

7 January 2021

Effectiveness of pneumococcal vaccination for elderly people in Catalonia, Spain: a case-control study

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.02.024

7 January 2021

Incremental effectiveness of pneumococcal vaccine on simultaneously administered influenza vaccine in preventing pneumonia and pneumococcal pneumonia among persons aged 65 years or older

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.02.024

7 January 2021

Randomised trial of 23-valent pneumococcal capsular polysaccharide vaccine in prevention of pneumonia in middle-aged and elderly people. Swedish Pneumococcal Vaccination Study Group

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.02.024

7 January 2021

Effect of influenza and pneumococcal vaccines in elderly persons in years of low influenza activity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.02.024

7 January 2021

Clinical effectiveness of 23-valent pneumococcal polysaccharide vaccine against pneumonia in middle-aged and older adults: A matched case–control study

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.02.024

7 January 2021

Effectiveness of the 23-valent pneumococcal polysaccharide vaccine against community-acquired pneumonia in the general population aged ≥ 60 years: 3 years of follow-up in the CAPAMIS study.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.02.024

7 January 2021

The effectiveness of the polysaccharide pneumococcal vaccine for the prevention of hospitalizations due to Streptococcus pneumoniae community-acquired pneumonia in the elderly differs between the sexes: Results from the Community-Acquired Pneumonia O

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.02.024

7 January 2021

Additive preventive effect of influenza and pneumococcal vaccines in elderly persons

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.02.024

7 January 2021

Effectiveness of a 23-valent polysaccharide vaccine in preventing pneumonia and non-invasive pneumococcal infection in elderly people: a large-scale retrospective cohort study.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.02.024

7 January 2021

Effectiveness of pneumococcal polysaccharide vaccine against pneumonia and cost analysis for the elderly who receive seasonal influenza vaccine in Japan

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.02.024

7 January 2021

Effectiveness of pneumococcal polysaccharide vaccine in older adults

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.02.024

7 January 2021

Risk factors for community-acquired pneumonia in immunocompetent seniors

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.02.024

7 January 2021

Prevention of community-acquired pneumonia among a cohort of hospitalized elderly: benefit due to influenza and pneumococcal vaccination not demonstrated

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.02.024

7 January 2021

Prospective cohort study on the effectiveness of influenza and pneumococcal vaccines in preventing pneumonia development and hospitalization

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.02.024

7 January 2021

Community-Acquired Pneumonia Requiring Hospitalization among U.S. Adults

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.02.024

7 January 2021

Effect of pneumococcal vaccination in hospitalized adults with community-acquired pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.02.024

7 January 2021

Serotype-specific changes in invasive pneumococcal disease after pneumococcal conjugate vaccine introduction: a pooled analysis of multiple surveillance sites

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.02.024

7 January 2021

The effectiveness of pneumococcal polysaccharide vaccines in adults: a systematic review of observational studies and comparison with results from randomised controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.02.024

7 January 2021

Efficacy of pneumococcal vaccination in adults: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.02.024

7 January 2021

The 23-valent pneumococcal polysaccharide vaccine. Part I. Efficacy of PPV in the elderly: a comparison of meta-analyses.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.02.024

7 January 2021

Efficacy of pneumococcal polysaccharide vaccine in immunocompetent adults: a meta-analysis of randomized trials

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.02.024

7 January 2021

Are the pneumococcal polysaccharide vaccines effective? Meta-analysis of the prospective trials

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.02.024

7 January 2021

Preventing non bacteremic pneumococcal pneumonia in older adults: historical background and considerations for choosing between PCV13 and PPV23.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.02.024

7 January 2021

Effectiveness of 23-valent pneumococcal polysaccharide vaccine against invasive disease and hospital-treated pneumonia among people aged ≥65 years: a retrospective case-control study

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.02.024

7 January 2021

Increasing incidence of invasive pneumococcal disease and pneumonia despite improved vaccination uptake: surveillance in Hull and East Yorkshire, UK, 2002-2009.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.02.024

7 January 2021

Clinical effectiveness of pneumococcal polysaccharide vaccine in men: California Men's Health Study

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.02.024

7 January 2021

Effectiveness of the pneumococcal polysaccharide vaccine in preventing pneumonia in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.02.024

7 January 2021

Invasive pneumococcal disease in non-Indigenous people in north Queensland, 2001-2009.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.02.024

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2016.02.024

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38743116&oldid=1782295336"